FDA Drug recall D-0077-2023
Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01
- FDA Drug
- Class II
- terminated
- Published 2022-12-14
On 2022-12-14 the FDA classified a Class II recall of Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01 by Remedyrepack, citing subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0077-2023 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2022-12-05 |
| Published | 2022-12-14 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Remedyrepack |
| Distribution | MI |
Product
Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816; Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC #: 70518-3493-00.
Reason
Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
Identifiers
| code_info | Lot # B1817019-082222, Exp. 02/24/2023; B1819127-082322, Exp. 02/26/2023 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0077-2023%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.